| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |